# E2E PHARMA LLC – FDA Inspection, Jun 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/e2e-pharma-llc/156f0738-9dce-4a30-a867-6cc24ee3705b
Source feed: FDA_Inspections

> FDA inspection 1321390 of E2E PHARMA LLC, June 10, 2026. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 111. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1321390
- Company Name: E2E PHARMA LLC
- Inspection Date: 2026-06-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Food Composition, Standards, Labeling and Econ
- Product Type: Foods & Cosmetics
- Center: Foods & Cosmetics
- Office Name: Denver District Office
- Citation Count: 8

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/alan-escalona/4f373343-dbf7-4baf-b579-9b9b13162aa6)

Company: https://www.keypedia.com/companies/e2e-pharma-llc/213d5b38-2a2b-4882-bfc0-f9b9939e12b0

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face